JENNIFER BERGEN: Open Payments
NPI 1710725767 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 16 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $86 |
| PFIZER INC. | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 1 | $35 |
| Bausch Health US, LLC | 2 | $31 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $28 |
| Gilead Sciences, Inc. | 1 | $27 |
| Exact Sciences Corporation | 1 | $26 |
| Corium, LLC | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $23 |
Products named: UBRELVY, REXULTI, APLENZIN, PREVNAR 20, The Cologuard Plus Collection Kit, NURTEC ODT, AIRSUPRA, VIBERZI.
Industry payments across IL — which companies pay providers there.
